ACE and kidney cancer: A recent meta-analysis found a 2% higher incidence of kidney cancer with the use of antihypertensive drugs, particularly angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) 14, contrasting with studies suggesting that antihypertensive drugs may exert protective effects through antiangiogenic mechanisms and calcium regulation 15,16.